The European Union has slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the 27-nation bloc’s antitrust watchdog.
Source link
The European Union has slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the 27-nation bloc’s antitrust watchdog.
Source link
TetraBulletin is your news, entertainment, music fashion website. We provide you with the latest breaking news and videos straight from the entertainment industry.
Contact us: [email protected]

